| Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (NCT04592887) | Varian, a Siemens Healthineers Company | 2020-11-03 |
| Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer (NCT02480634) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2019-06-01 |
| Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival (NCT07100444) | Guangdong Provincial People's Hospital | 2018-01-01 |
| Validation of Radio-induced Damage Biomarkers (NCT02999152) | Centre Hospitalier Universitaire de Saint Etienne | 2017-06-22 |
| Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma (NCT02876991) | Central Hospital, Nancy, France | 2016-02-01 |
| Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy (NCT02609828) | Pfizer | 2015-10-28 |
| Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy (NCT02426697) | Centre Henri Becquerel | 2015-05-22 |
| Bone Pain Score Validation Initiative (NCT02293642) | iOMEDICO AG | 2014-12-01 |
| A Trial of MBC-11 in Patients With CIBD (NCT02673060) | Osteros Biomedica Ltd | 2014-07-01 |
| A Study to Collect Data About Analgesia in Patients With Bone Metastasis (NCT02774213) | Tools4Patient | 2014-07-01 |
| Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors (NCT02784652) | Severance Hospital | 2014-06-01 |
| A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain (NCT01833806) | InSightec | 2013-09-01 |
| Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw (NCT01998607) | Amgen | 2013-02-04 |
| Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU) (NCT01765907) | Theraclion | 2012-12-01 |
| Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases (NCT01586273) | Philips Healthcare | 2012-09-01 |
| Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases (NCT01309048) | Philips Healthcare | 2011-01-01 |
| Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC (NCT01062503) | University Health Network, Toronto | 2010-01-01 |
| Optimization of Radiotherapy in Treatment of Painful Bone Metastasis (NCT00610272) | International Atomic Energy Agency | 2008-01-01 |
| Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer (NCT00334139) | Novartis Pharmaceuticals | 2006-05-01 |
| Chemoradiation for Bone Metastasis (NCT01784393) | Rabin Medical Center | 2004-05-01 |
| Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer (NCT02011880) | Shanghai University of Traditional Chinese Medicine | |